Compound Detail
CHEMBL1201087
CABERGOLINE 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
C=CCN1C[C@H](C(=O)N(CCCN(C)C)C(=O)NCC)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21
Basic Information
| ChEMBL ID | CHEMBL1201087 |
| Name | CABERGOLINE |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | KORNTPPJEAJQIU-KJXAQDMKSA-N |
| Therapeutic | ✓ Yes |
5
Targets
8
Activities
2
Assay Types
0
PK Parameters
20
Publications
7
Known Names
15
Indications
1
Mechanisms
Molecular Properties
451.6
MW (Da)
3.19
ALogP
4
HBA
2
HBD
71.7
PSA (Ų)
0.60
QED
0
Ro5 Violations
8
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 1996 |
| Availability | Prescription |
| Chirality | Single Enantiomer |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Dopamine D2 receptor agonist | AGONIST | D(2) dopamine receptor | ✓ | ✓ |
Indications
Parkinson Disease Pituitary Neoplasms Diabetes Mellitus Ovarian Hyperstimulation Syndrome Restless Legs Syndrome Cocaine-Related Disorders Cocaine-Related Disorders Endometriosis Infertility Paget Disease, Extramammary Pituitary ACTH Hypersecretion Polycystic Ovary Syndrome Obesity Substance-Related Disorders Breast Neoplasms
ATC Classification
G02CB03
cabergoline
Level 1: GENITO URINARY SYSTEM AND SEX HORMONES
Level 2: OTHER GYNECOLOGICALS
N04BC06
cabergoline
Level 1: NERVOUS SYSTEM
Level 2: ANTI-PARKINSON DRUGS
Activity Summary
Ki 5 meas. best 9.44
EC50 3 meas. best 7.89
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| D(2) dopamine receptor CHEMBL217 | Ki | 9.44 | 9.44 | 0.4 | 2 |
| 5-hydroxytryptamine receptor 2B CHEMBL1833 | Ki | 8.85 | 8.85 | 1.4 | 1 |
| D(1A) dopamine receptor CHEMBL2056 | Ki | 8.85 | 7.135 | 1.4 | 2 |
| 5-hydroxytryptamine receptor 2B CHEMBL1833 | EC50 | 7.89 | 7.89 | 13.0 | 1 |
| Dopamine receptor CHEMBL2096905 | EC50 | 7.89 | 7.89 | 13.0 | 1 |
| Alpha-2A adrenergic receptor CHEMBL1867 | EC50 | 6.54 | 6.54 | 285.4 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| - | 10.6019/CHEMBL5724801 | HEK-293T | 304 |
| - | 10.6019/CHEMBL5058577 | Fibroblast | 304 |
| - | 10.6019/CHEMBL5058577 | U2OS | 304 |
| - | 10.6019/CHEMBL5058577 | HEK-293T | 304 |
| - | 10.6019/CHEMBL5724801 | U2OS | 304 |
| - | 10.6019/CHEMBL5724801 | Fibroblast | 304 |
| 16472241 | 10.2174/1570163043334794 | Hepatotoxicity | 18 |
| 22194678 | 10.1371/journal.pcbi.1002310 | Hepatotoxicity | 14 |
| - | 10.6019/CHEMBL5209801 | Free fatty acid receptor 4 | 8 |
| - | 10.6019/CHEMBL5209801 | Apelin receptor | 8 |
| - | 10.6019/CHEMBL5209801 | Sphingosine 1-phosphate receptor 1 | 8 |
| - | 10.6019/CHEMBL5209801 | Beta-2 adrenergic receptor | 8 |
| - | 10.6019/CHEMBL5209801 | Adhesion G-protein coupled receptor F1 | 8 |
| - | 10.6019/CHEMBL5209801 | N-formyl peptide receptor 2 | 8 |
| - | 10.6019/CHEMBL5209801 | CX3C chemokine receptor 1 | 8 |
| - | 10.6019/CHEMBL5209801 | C5a anaphylatoxin chemotactic receptor 1 | 8 |
| - | 10.6019/CHEMBL5209801 | Glucagon-like peptide 1 receptor | 8 |
| - | 10.6019/CHEMBL5209801 | Alpha-2A adrenergic receptor | 8 |
| - | 10.6019/CHEMBL5209801 | Glucose-dependent insulinotropic receptor | 8 |
| - | 10.6019/CHEMBL5209801 | Type-1 angiotensin II receptor | 8 |
Data from ChEMBL 36 via Core Engine